Stye Gel
NDC Package 63736-238-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Stye (mineral oil and petrolatum) gel is pull down the lower lid of the affected eye and apply a small amount (one-fourth inch) of ointment to the inside of the eyelid. This formulation utilizes a gel delivery system. Marketed by Insight Pharmaceuticals Llc, this product is identified by NDC 63736-238 and is authorized under FDA application M018.

Identification & Billing

NDC Package Code
63736-238-24
Package Description
24 BOX in 1 CASE / 1 TUBE in 1 BOX / 3.5 g in 1 TUBE
Product Code
63736-238
11-Digit Billing Format
63736023824
RxNorm Crosswalk
  • RxCUI: 1053146 - Stye 31.9 % / 57.7 % Ophthalmic Ointment
  • RxCUI: 1053146 - mineral oil 0.319 MG/MG / petrolatum 0.577 MG/MG Ophthalmic Ointment [Stye]
  • RxCUI: 1053146 - Stye (mineral Oil 0.319 MG/MG / petrolatum, white 0.577 MG/MG) Ophthalmic Ointment
  • RxCUI: 1053146 - Stye (mineral oil 31.9 % / petrolatum, white 57.7 % ) Ophthalmic Ointment
  • RxCUI: 579999 - mineral oil 31.9 % / petrolatum 57.7 % Ophthalmic Ointment

Clinical Specifications

Proprietary Name
Stye
Non-Proprietary Name
Mineral Oil And Petrolatum
Substance Name
Mineral Oil; Petrolatum
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Ophthalmic - Administration to the external eye.
Active Ingredient(s)
Usage Information
Pull down the lower lid of the affected eye and apply a small amount (one-fourth inch) of ointment to the inside of the eyelid

Regulatory & Marketing

Labeler Name
Insight Pharmaceuticals Llc
Product Type
Human Otc Drug
FDA Application #
M018
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-15-2010
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63736-238-24 identifies a specific commercial package of 24 box in 1 case / 1 tube in 1 box / 3.5 g in 1 tube of Stye, a human over the counter drug labeled by Insight Pharmaceuticals Llc. This gel is formulated for ophthalmic use and contains mineral oil; petrolatum as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Insight Pharmaceuticals Llc on June 15, 2010. The current certification is valid through December 31, 2026.

How is this Insight Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63736023824. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63736-238-24
11-Digit CMS (5-4-2)
63736-0238-24

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.